Prescribing information 2026
Medications that mimic GLP-1 (like semaglutide and tirzepatide) are FDA-approved for: Type 2 diabetes management (Ozempic) Chronic weight management (Wegovy, Zepbound, and Mounjaro) These drugs help reduce appetite, slow digestion, and improve metabolic efficiencyall of which support gradual, sustainable weight loss
If you're a patient who's had insomnia or sleep apnoea, you've lost weight, so your sleep is better, you're feeling better about yourself, you're eating better, and yes, your activity level is going to increase
If you use them as permission to not fix your sleep, stress, and basic nutrition, youre missing the point entirely
a claim for CPT code 96372 without an accompanying drug code will be questioned by payers on medical necessity grounds
Combined use increases the risk of respiratory depression and complicates clinical management